AICAR is a potent activator of AMP-activated protein kinase (AMPK), a master regulator of cellular energy homeostasis. By mimicking a low-energy state, it stimulates glucose uptake and fatty acid oxidation, earning it the nickname 'exercise in a pill'. Its relevance to longevity is purely theoretical, based on the central role of the AMPK pathway in metabolic health and stress resistance, but it lacks human data for this purpose.
Verdict
A high-risk research chemical with no proven human healthspan benefits.
HEALTHSPAN IMPACT
Experimental
RISK LEVEL
Very High
EVIDENCE GRADE
C
MONTHLY COST
$500 - $2000
Protocol
- No established protocol exists for human healthspan; this is a research chemical not approved for human use.
Flags
- Not approved for human consumption; sourced as a 'research chemical'.
- Banned by the World Anti-Doping Agency (WADA).
- Potential for profound metabolic disruption and unknown long-term side effects.
- Theoretical concerns about altering nucleotide pools, potentially impacting cancer risk.
- Extremely poor oral bioavailability requires injection for systemic effects.